Your browser doesn't support javascript.
loading
Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study.
Zhang, Tian-Qi; Geng, Zhi-Jun; Zuo, Meng-Xuan; Li, Ji-Bin; Huang, Jin-Hua; Huang, Zi-Lin; Wu, Pei-Hong; Gu, Yang-Kui.
Afiliación
  • Zhang TQ; Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Geng ZJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
  • Zuo MX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
  • Li JB; Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Huang JH; Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Huang ZL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
  • Wu PH; Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Gu YK; Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Signal Transduct Target Ther ; 8(1): 413, 2023 10 27.
Article en En | MEDLINE | ID: mdl-37884523
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Signal Transduct Target Ther Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Signal Transduct Target Ther Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido